Bio Protocol vs Nibiru Chain — how do they compare? Bio Protocol trades at Rp441.61 (market cap Rp1,01T, Rp168,09M 24h volume), while Nibiru Chain trades at Rp35.29 (market cap Rp55,17M, Rp4,69M 24h volume). The key difference: Bio Protocol is far larger — about 18307.1× Nibiru Chain's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 954M / 1,5B NIBI (64%) for Nibiru Chain. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Nibiru Chain for 7 Days on average.
| BIO | NIBI | |
|---|---|---|
Market Cap | Rp1,01T | Rp55,17M |
Volume (24h) | Rp168,09M | Rp4,69M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 954M / 1,5B NIBI (64%) |
Typical Hold Time | 18 Days | 7 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Nibiru Chain is a groundbreaking Layer 1 blockchain and smart contract ecosystem that offers exceptional throughput and unmatched security. Nibiru strives to be the most developer-friendly and user-friendly smart contract ecosystem, leading the way toward mainstream Web3 adoption. It achieves this by innovating at every layer of the technology stack, including dApp development, infrastructure, consensus mechanisms, a comprehensive developer toolkit, and value accrual.
Read more on NIBI →